Abstract Connexins, assembled as a hexameric connexon, form a transmembrane hemichannel that provides a conduit for paracrine signalling of small molecules and ions to regulate the activity and function of adjacent cells. When hemichannels align and associate with similar channels on opposing cells, they form a continuous aqueous pore or gap junction, allowing the direct transmission of metabolic and electrical signals between coupled cells. Regulation of gap junction synthesis and channel activity is critical for cell function, and a number of diseases can be attributed to changes in the expression/function of these important proteins. Diabetic nephropathy is associated with several complex metabolic and inflammatory responses characterised by defects at the molecular, cellular and tissue level. In both type 1 and type 2 diabetes, glycaemic injury of the kidney is the leading cause of end-stage renal failure, a consequence of multiple aetiologies, including increased deposition of extracellular matrix, glomerular hyperfiltration, albuminuria and tubulointerstitial fibrosis. In diabetic nephropathy, loss of connexin mediated cell-cell communication within the nephron may represent an early sign of disease; however, our current knowledge of the role of connexins in the diabetic kidney is sparse. This review highlights recent evidence demonstrating that maintenance of connexin-mediated cell-cell communication could benefit region-specific renal function in diabetic nephropathy and suggests that these proteins should be viewed as a tantalising novel target for therapeutic intervention.
Introduction
Efficient renal function depends on cooperation between cells of the nephron and cells of the renal vasculature. Gap junctions permit direct intercellular transfer of small molecules and ions and are formed from the alignment of two connexons on adjoining cells [1] . Each connexon is composed of a hexameric assembly of connexins that make up a transmembrane pore called a hemichannel [1] . When hemichannels align with those on neighbouring cells they 'dock' to form an aqueous pore permitting the transmission of metabolic and electrical signals between coupled cells facilitating cellular activity and synchronising tissue function. Most cells communicate with their immediate neighbours via gap junctions, and multiple connexin isoforms are expressed in the kidney [2] . However, whilst the presence of gap junctions has long been known, we have only recently begun to understand how connexins regulate renal function. Expressed in the renal vasculature, connexins have been demonstrated to contribute to the regulation of both GFR and renin secretion, thus suggesting a role for connexins in the regulation of blood pressure [3, 4] . This critical function rightly warrants our attention. However, connexins are also highly expressed in tubular epithelium, where their role is far less certain. Elevated glucose in diabetes dramatically alters connexin expression, and it seems likely that changes in cell-cell communication play a critical role in the aetiology and pathophysiology of the disease [5] [6] [7] [8] [9] [10] .
In patients with diabetes, nephropathy represents the leading cause of end-stage renal disease (ESRD) and is the leading cause of entry into the renal replacement therapy programme. Sadly, renal complications of diabetes account for approximately 21% of deaths in patients with type 1 and approximately 11% of deaths in patients with type 2 [11] . As the incidence of diabetes continues to increase, there is a pressing demand to identify future therapeutic targets to alleviate debilitating complications such as diabetic nephropathy. Associated with complex metabolic and inflammatory changes, diabetic nephropathy is characterised by defects at the molecular, cellular and tissue level [12] . Alterations in the expression of key candidate proteins pivotal to cell communication could contribute to the development and progression of key underlying pathologies of diabetic nephropathy. In the current article we review expression, localisation and function of connexins throughout the diabetic kidney and explore how glucose and its downstream pro-fibrotic mediators alter these important proteins.
Connexins, connexons, gap junctions and hemichannels
Connexins are a family of transmembrane proteins critical for intercellular communication. In humans, there are 21 genes known to be associated with the connexin family. Commonly designated by numerical suffixes referring to their molecular weight, the expression of these proteins may be ubiquitous (CX32, CX37, CX40, CX43 and CX45), e.g. CX32 is expressed in numerous cells, including cardiac tissue, the kidney and hepatocytes, or tissue specific, e.g. CX62 is expressed only in retinal tissue [13] . The biosynthesis and export of connexin polypeptides to the cell membrane is similar to other membrane bound proteins, with membrane insertion denoting topographic arrangement [14] . However, with a half-life of only a few hours, connexins are subjected to a continuous cycle of synthesis and degradation, a process that allows for acute regulation of channel activity and gap junction-mediated cell communication [14] .
Sharing common structural features, connexins are composed of four transmembrane helices interconnected by two extracellular loops, one intracellular loop, and cytoplasmic -NH 2 and -COOH terminal regions. Whilst the highly conserved -NH 2 terminal tail incorporates a putative calmodulinbinding motif, which is necessary for membrane insertion, both the -NH 2 terminal tail and -COOH terminal region are thought to play a central role in the regulation of channel conductance, being controlled by phosphorylation and posttranslational modification [15, 16] . Phosphorylation of connexins can occur on either serine/threonine or tyrosine residues, and changes in conductance and/or permeability may have implications for the assembly, degradation and biosynthesis of gap junctions [17] .
Gap junctions are formed through interaction between two connexons, or hemichannels, on the membrane of adjacent cells. Connexons are hexameric structures comprised of six individual connexins, and the resultant junction contains a 1-2 nm diameter aqueous pore, through which ions and small molecules, including Ca 2+ , ATP, cAMP, Na + and IP 3 pass [18] . Depending on the combination of connexin isoforms, connexons can either be homomeric or heteromeric (see Fig. 1 ). As stand-alone structures, hemichannels form when connexons are inserted into the membrane without association with another connexon on a neighbouring cell [18] . Hemichannels are also permeable to a variety of small metabolites and have been shown to contribute to paracrine signalling [19] .
The composite connexin isoforms of a given gap junction determine the selectivity of molecules able to migrate through the junction (i.e. its permeability), which, in turn, is determined by the diameter and charge of the pore formed. For example, CX43 exhibits a greater affinity for AMP, ADP and ATP as compared with CX32, whilst CX32 has a 12-fold higher affinity for adenosine [20] . It is the ability of different isoforms to combine that lends itself to diversity in terms of permeability, selectivity and conductance, with conductance not just controlled by isoform homology but also by various stimuli, including pH, Ca 2+ and post-translational modification. It remains to be determined whether gap junction assembly and membrane insertion is random or site directed. What is known is that extracellular matrix (ECM) proteins, cadherins, integrins and laminins are required to facilitate their adhesion once inserted into the membrane [21, 22] .
The number of diseases attributed to mutations and single nucleotide polymorphisms in proteins involved in regulation of gap junction synthesis and channel activity suggest that functional gap junctions are critical for cell function [23] . Connexins have a role in ischaemia [24] , inflammation [25] and both renin-induced and essential hypertension [26, 27] . Furthermore, the relationship between hyperglycaemia and a loss of gap junction expression is important in the progression and development of multiple microvascular complications in diabetes [28] . Effects of hyperglycaemia on gap junction intercellular communication (GJIC) have been examined in multiple tissue types, and there are reports that glucose decreases gap junction conductance and disrupts cellular homeostasis in various cell systems, including retinal pericytes [5] , endothelial cells [6] and epithelial cells [29] . A glucoseevoked reduction of CX43 in retinal capillaries of diabetic mice results in increased apoptosis, loss of cell communication and a decline in pericyte and acellular capillary number [5] . Loss of CX43 in vascular cells of diabetic rats impairs ventricular induction, suggesting that a loss of GJIC may also contribute towards cardiovascular complications of diabetes [30] . However instigated, it is clear that a glucose-induced loss of connexin-mediated cell-cell communication is important in the development of several facets of this debilitating metabolic disease.
The role of connexins in the diabetic kidney
In the kidney, multiple structural and functional changes occur in response to elevated levels of glucose, including those that occur in the glomerulus, tubulointerstitium and vasculature [12] . Structural abnormalities range from thickening of the glomerular basement membrane, hypertrophy, interstitial fibrosis and tubular atrophy [12] . Together, these changes contribute to glomerular hyperfiltration, albuminuria, systemic hypertension and loss of renal function [12] . Of the 21 connexin isoforms expressed in humans, nine are found in the tubular and vascular regions of the kidney (CX26, CX31, CX30.3, CX37, CX32, CX40, CX43, CX45 and CX46) (for a review, see [2] ). However, our understanding of how changes in gap junctions in the kidney facilitate progression of diabetic nephropathy is limited. The following sections discuss our current knowledge for a role of connexins in the nephron, specifically, the renal vasculature, mesangium and podocytes.
Vasculature CX37, CX40 and CX43 are present within endothelial cells of the rat afferent arteriole, whilst only CX43 appears to be expressed by the post-glomerular vasculature [2] . For cells of the pre-glomerular vessels to communicate efficiently, they must be functionally coupled. Loss of synchronised cell communication may pre-dispose the development of early changes that underline the onset of diabetic nephropathy. This notion is supported by the presence of modified levels of both CX40 and CX43 in streptozotocin (STZ)-treated mice. In non-diabetic mice, CX40 is expressed on the endothelium from afferent arterioles, whilst CX43 is localised to efferent arterioles. However, following STZ ablation of insulin-secreting pancreatic beta cells, expression of CX40 was found to be increased in afferent arterioles and inside the glomerulus, whilst expression of endothelial CX43 in efferent arterioles was decreased [7, 8] .
The role of CX40 in regulating blood pressure by modulating renin secretion is well documented. Renin is released by the juxtaglomerular apparatus and controls extracellular volume through changes in angiotensin II and mean arterial pressure [31] . Renin-producing cells are linked by CX40-mediated gap junctions and are highly electrically coupled [32, 33] . Knocking out the gene encoding CX40 (Gja5 −/− mice) makes these animals hypertensive [32] . It has previously been reported that renin-dependent hypertension experimentally induced by the clipping of a renal artery in the two-kidney, one-clip (2K1C) model is associated with a vessel-specific increase in the expression of CX43 [34] . However, when CX43 expression is repressed and replaced with CX32, there is a marked reduction in renin secretion and mice are normotensive [35] . These findings have recently been questioned by Gerl et al who, using mice with Channel:
Homotypic Homotypic Heterotypic Heterotypic Fig. 1 Gap junction assembly may be homotypic or heterotypic. Gap junction formation occurs when connexons on adjacent cells align to form either a homotypic or heterotypic structure. Whether the connexon is defined as homomeric or heteromeric is dependent on the nature of the connexin isoform present. If a gap junction comprises two identical hexameric structures, then the channel is rendered homotypic. However, if the composition of each aligning connexon is different as a consequence of multiple connexin isoforms, then the channel is defined as heterotypic endothelium and renin cell-specific deletions of CX43, failed to confirm a requirement for CX43 in either renin expression or secretion in animals on either a normal salt diet or during chronic challenge of the renin system by pretreatment with a low-salt diet in the absence or presence of an ACE inhibitor [36] . In addition to controlling renin secretion, there is a link between connexins and glomerular hyperfiltration. Takenaka et al examined altered gap junction communication and abnormalities in renal haemodynamics in the Zucker Lean (ZL) rat and the Zucker Diabetic Fatty (ZDF) rat model of type 2 diabetes [37] . They reported that ZDF rats exhibit glomerular hyperfiltration with impaired autoregulation. The increase in GFR was linked to increased phosphorylation of CX43 and reduced CX37 expression in renin-secreting cells, suggesting that impaired GJIC in the juxtaglomerular apparatus mediates, or in part contributes to, altered renal autoregulation in the disease [37] . These data suggest that dysregulation of CX37, CX40 and CX43 contributes to impaired autoregulation, glomerular hyperfiltration and dysregulated blood pressure homeostasis.
Mesangium Ultrastructural and histochemical studies indicate the existence of a high density of gap junctions among mesangial cells, but little is known about their regulation. In diabetic nephropathy, mesangial cell proliferation has been proposed to play a role in the progression of glomerulosclerosis [38, 39] . Glomerular mesangial cells are highly coupled by CX43-containing gap junctions, with expression levels mirrored by GJIC [40] . Expression levels of CX43 are downregulated in mesangial and endothelial cells of STZ-induced diabetic rats [41] , whilst exposure of rat glomerular mesangium to platelet-derived growth factor evokes a phosphoinositide 3-kinase-dependent loss of CX43-mediated GJIC [42] . This loss of cell communication, Yao et al propose, may in part contribute to the complex interplay of events that accompany mesangial cell proliferation in forms of renal disease, including diabetic nephropathy [42] . In support of these studies, recent findings by Morioka et al have confirmed that CX40 expression in mesangial cells is related to mesangial cell regeneration, suggesting that connexin expression could be a therapeutic target for glomerular disease [43] .
Mesangial expansion is a hallmark of early diabetic nephropathy and is regarded as the structural variable that best correlates with dysregulated GFR, proteinuria and hypertension [44] . Exposure of cultured glomerular mesangial cells to high glucose evokes arrest in the G1 (senescence) phase of the cell cycle [45] . Zhang et al confirmed that a glucose-evoked reduction in CX43 accelerated the progression of mesangial cells through senescence, a state of arrested cell growth linked to mesangial cell hypertrophy in diabetic nephropathy [45] . In support of this, glucose-induced hypertrophy of mesangial cells was reversed by overexpressing CX43 via the phosphatase and tensin homologue/Akt/mechanistic target of rapamycin (PTEN/Akt/mTOR) pathway [46] . These studies suggest that high glucose levels downregulate mesangial CX43 expression, inducing cell cycle arrest, inhibition of proliferation and promotion of protein synthesis and hypertrophy of the mesangium, thus highlighting the possibility of CX43 as a future therapeutic target to both modulate cell hypertrophy and prevent mesangial expansion in diabetic nephropathy [46] .
Through interactions with numerous cell signalling and cell scaffold proteins, connexins are known to play a crucial role in cell adhesion, proliferation and migration. The carboxy tail of CX43 interacts with c-Src, a non-receptor tyrosine kinase that can regulate cell proliferation. Activated c-Src phosphorylates CX43 on tyrosine residues Tyr265 and Tyr247, ultimately impairing and reducing GJIC [47, 48] . Elevated levels of c-Src have been linked to the pathogenesis of diabetic nephropathy [49] . Furthermore, studies by Xie et al revealed that overexpression of CX43 or inhibition of c-Src not only attenuates the upregulation of glucose-induced intercellular adhesion molecule 1 (ICAM1), TGF-β1 and fibronectin expression in glomerular mesangial cells, but promotes and contributes to nuclear factor-κB activation, leading to renal inflammation [41] .
Abnormalities in renal NO generation have also been linked to the pathogenesis of renal disease in diabetes [50] [51] [52] . Whilst intrarenal NO production mediated primarily by constitutively released NO is increased in the early phases of diabetic nephropathy, a progressive decline in NO production and, specifically, NO bioavailability in the kidney has been observed with advancing renal failure [53] . A potential role of NO in the regulation of gap junction intercellular communication was suggested by Yao et al, who confirmed that increased NO augments CX43-mediated GJIC; an effect they found to be dependent on protein kinase A [54] . Their observations were the first to suggest that diminished NO in diabetic nephropathy may in part mediate a loss of gap junction-mediated cell communication in mesangial cells.
In addition to contributing to gap junction formation, uncoupled hemichannels permit local paracrine release of nucleotides (see Fig. 2 ) [19] . The gating of hemichannels is controlled by various physiological stimuli, including changes in membrane depolarisation, ionic concentration, mechanical stimulation and metabolic inhibition.
Like gap junctions, hemichannels have a role in both cell survival and cell death [19] . Hemichannel-mediated ATP release has recently been linked to the progression and development of fibrosis in cardiac fibroblasts, data that suggests a potential pathophysiological role for dysregulated hemichannel-mediated ATP signalling [55] . Oxidative stress can open CX43 hemichannels [56] . A recent study examined a role for boldine, an alkaloid with antioxidant, anti-inflammatory, and hypoglycaemic effects in the reversal of renal complications in the STZ-induced diabetic rat [57] . The study demonstrated that under resting conditions, mesangial hemichannels had a low open-state probability. However, glucose, IL-1β and TNF-α all increased hemichannel activity, even at negative membrane potential and in the presence of extracellular divalent cations [57] . Furthermore, when exposed to high glucose and proinflammatory cytokines, mesangial cells exhibited reduced gap junction-mediated cell coupling, effects that were reversed by co-administration with boldine. Interestingly, cells cultured in high glucose in the presence of proinflammatory cytokines, exhibited a slight, but insignificant increase in CX43 expression, whilst addition of boldine to the high glucose and proinflammatory cytokines led to a statistically significant elevation in CX43 expression as compared with control. These results demonstrate that when exposed to a diabetic milieu, mesangial cells exhibit increased hemichannel activity and impaired gap junction-mediated cell communication-an effect abolished by co-incubation with boldine [57] . The authors suggest that the boldine-induced increase in CX43 may account for newly synthesised gap junctions and explain the increase in coupled cells when coadministered with proinflammatory cytokines. Boldine may protect the kidney against oxidative stress by preventing hemichannel opening and ensuring cells remain successfully coupled to each other via gap junctions.
Podocytes Impaired renal function in diabetic nephropathy is a consequence of a number of underlying pathologies that ultimately stem from the loss in viable nephrons. In the majority of cases, this process is initiated in response to podocyte injury. Whilst podocyte injury or podocyte loss in the renal glomerulus has been proposed as the crucial mechanism in the development of glomerulosclerosis, our understanding of how podocytes respond to injury is limited. Previous studies have shown that CX43 is expressed on podocytes in both normal and diseased kidney tissue [58, 59] . Initial studies by Yaoita et al reported increased CX43 expression levels in the early to nephrotic stage of puromycin aminonucleoside-induced nephrosis in rats, an event they suggest may represent an early marker of podocyte injury [60] . Further to these findings, and given that oxidative stress mediates podocyte injury under a variety of pathological situations, Yan et al have reported that exposure of podocytes to puromycin evokes an increase in both NADPH oxidase 4 (NOX4) expression and superoxide generation [61] . Furthermore, inhibition of NADPH oxidase attenuated the puromycin-induced increase in CX43 expression, whilst treatment of podocytes with several structurally different gap junction inhibitors significantly attenuated the cytotoxicity of puromycin, thus suggesting that NADPH oxidase-mediated upregulation of CX43 contributes to podocyte injury [61] . Finally, failure of Lucifer yellow dye to transfer between parietal epithelial cells of the Bowman's capsule, led to the suggestion that podocytes may respond to injury as an integrated epithelium on a glomerulus rather than individually as a separate cell [60] .
Our knowledge of podocyte gap junctions and their role in diabetic kidney disease is sparse. Studying renal biopsies and podocytes from patients with type 2 diabetes and comparing these with nephrectomised kidney samples from individuals with localised neoplasm or minor glomerular abnormalities, Sawai et al [62] observed a loss of CX43 expression in patients with overt nephropathy. To retain renal function, the loss of podocytes and glomerular hypertrophy in diabetic nephropathy must be compensated for. To this end, podocytes migrate and extend their cell body over the glomerular basement membrane depleted of functioning podocytes. Sawai et al proposed that a loss of CX43 and redistribution away from points of cell-cell contact, impaired podocyte cell communication and contributed to the loss of barrier function leading to albuminuria [62] . They hypothesised that CX43 and cAMP, black dots). When connexons lack a binding partner on a neighbouring cell, e.g. Cell 3, undocked hemichannels provide a conduit for the efflux of these small cytosolic molecules and ions into the intercellular space immediately surrounding the cell (e.g. ATP, red dots). The limited volume of this intercellular space allows the concentration of agonists to increase (↑[ATP]e) to levels capable of evoking a receptor-mediated response on adjacent cells expressing the appropriate receptor, e.g. Cell 2 expressing P2Y purinoreceptors. This local paracrine transfer of information provides an alternative route for synchronising cellular activity directly interferes with tight junctions and cytoskeletal proteins, ultimately impairing slit diaphragm components essential for the selective filtering process. As a consequence of this important study, CX43 staining may represent an easy and convenient means of assessing podocyte damage and renal function in diabetic nephropathy.
Connexins, cell-cell communication and renal fibrosis
Diabetic nephropathy is histologically characterised by increased expression of interstitial matrix components and an accumulation of the ECM in both the glomerular mesangium and tubular interstitium, together culminating in excessive renal scarring and a decline in excretory function [12] . Renal fibrosis presents as glomerulosclerosis, tubulointerstitial fibrosis, infiltration of inflammatory mediators and the activation of alpha-smooth muscle actin-positive myofibroblasts [63, 64] . Of these, tubulointerstitial fibrosis is the key pathology underlying diabetic nephropathy, with fibrosis and the subsequent loss of cell function being a predictive marker for ESRD. Understanding the signals that regulate the deposition of fibrotic material in the interstitium is important for developing site-directed therapies that may help alleviate this damage.
Central to tubulointerstitial fibrosis is tubular epithelial-tomesenchymal transition (EMT), or the trans-differentiation of tubular epithelial cells into myofibroblasts [63] . In diabetic nephropathy, EMT occurs as cells attempt to avoid apoptosis in the presence of high glucose. Ultimately, cells undergo a number of morphological and phenotypic changes in which they lose classic epithelial characteristics in exchange for markers more commonly associated with a mesenchymal phenotype. This trans-differentiation occurs at four distinct stages. The pivotal step of EMT is denoted by a loss of epithelial (E)-cadherin and the subsequent loss of cell-cell adhesion. This is further accompanied by a loss of epithelial proteins central to tight junction formation, e.g. claudin and the zonula occludens protein (ZO-1), whilst cytoskeletal remodelling is accompanied by the loss of cytokeratin expression, replaced by the intermediate filament protein vimentin and alpha-smooth muscle actin. Together, these morphological changes result in loss of cell adhesion and tubular basement membrane disruption which, when combined with expression of fibroblast specific protein 1, results in the production of a newly defined group of cells that exhibit enhanced motility and increased proliferative and contractile capacity. These cells migrate from the tubular basement membrane into the interstitium where they reside as fibrotic mediators, an event that leads to increased deposition of the ECM [64] .
Tissue integrity is maintained by cell-cell and cell-substrate (ECM) adhesion. Adhesion is multifunctional, providing structural support and a link between the cell and its environment. Loss of adhesion precedes loss of function. In diabetic nephropathy, impaired E-cadherin mediated cell-cell adhesion represents a pivotal step in early proximal tubular injury [63, 64] . Cadherins help form the multi-protein adherens junction that links cell-cell contact to the actin cytoskeleton and various signalling molecules. In epithelial cells, connexins co-localise with cadherins and, consequently, gap junctions form close to the site of intercellular adhesion, where they mediate GJIC [21] . Inhibiting cadherin-based cell adhesion inhibits gap junction assembly and impairs cell-cell communication [65] , whilst upregulation of E-cadherindependent cell-cell contacts increases GJIC in mouse epidermal cells [66] . In human proximal tubule cells, glucoseevoked increases in TGF-β1 reduce CX43-mediated GJIC by reducing cell-cell adhesion [67] . Interestingly, some type 2 diabetic patients have been found to have elevated levels of visfatin, and this adipokine has recently been shown to inhibit expression of both CX26 and CX43 in the human kidney (HK2) proximal tubule cell line [68] .
In wound healing, deposition of the ECM is a response to renal injury, whilst excessive matrix deposition is a hallmark of fibrosis and occurs when cells of the nephron over compensate in their attempt to maintain function [69] . Therefore, a tight balance between synthesis and breakdown of matrix proteins is required. One mechanism of control is through regulation of collagen and matrix metalloproteinase (MMP) production [70] . Loss of this regulation can tip the balance from repair to injury, culminating in a build-up of fibrotic material and scar formation. Recent studies examining the role of connexins in wound healing in human diabetic fibroblasts and keratinocytes suggest that an increase in cell motility may occur as a consequence of decreasing both gap junction and hemichannel activity [71] . Furthermore, keratinocytes exhibit a loss of CX43 expression at 24-48 h during the normal healing process as cells become migratory in an attempt to close the wound [72] . These studies suggest that a loss of connexin expression may facilitate wound healing, an observation that may have dramatic implications for scar formation and fibrosis in the diabetic kidney. In an STZ-induced mouse model, cell migration is delayed until connexin levels are downregulated [73] . Connexins form partnerships with multiple adhesion and structural proteins, e.g. CX43 forms a complex with ZO-1, β-catenin and neuralcadherin (N-cadherin), proteins likely to influence cell adhesion and wound healing. Not surprisingly, knockdown of CX43 in conjunction with the cell adhesion protein N-cadherin accelerates cell migration in a scratch wound healing assay [74] . These data, which are consistent with those presented by Hills et al [67] confirming a link between loss of connexin expression and impaired E-cadherin-mediated cell adhesion in the human proximal tubule, support the notion that both CX43 and adhesion proteins may represent therapeutic targets for improved wound repair and in alleviating tubulointerstitial fibrosis, where loss of connexin expression in the renal tubule may not only lead to impaired cell communication but may facilitate increased cell migration. In accordance with morphological and phenotypic changes linked to early tubular injury in diabetic nephropathy, loss of connexin-mediated communication and increased motility may facilitate the migration of cells into the interstitium, where they can reside as newly defined fibrotic mediators.
Contrary to the above, recent studies by Abed et al propose an opposite effect of impaired connexin expression. Having confirmed that biopsies of patients with chronic kidney disease exhibit elevated levels of CX43, they also confirmed that, when interbred with RenTg mice, a genetic model of hypertension-induced chronic kidney disease, Cx43 +/− mice exhibit a marked decrease in cell adhesion markers, which leads to reduced monocyte infiltration and interstitial renal fibrosis. In addition, functional and histological markers such as albuminuria and glomerulosclerosis were also ameliorated [75] . These differences in both expression and function however may of course be region specific and may be explained by an absence of hyperglycaemia.
Do connexins protect against diabetic nephropathy?
In the cortical collecting duct, efficient and appropriate reuptake of sodium depends upon an integrated response of the ductal epithelium to changes in osmolarity. This in turn relies on connexin-mediated coordination of cellular activity [76, 77] . Abnormal sodium reabsorption has been linked to the development of hypertension in both renal disease and diabetic nephropathy. Cells of the human cortical collecting duct express CX43 and the transient receptor potential cation channel subfamily V member 4 (TRPV4) ion channels [78] . Mechano-sensitive TRPV4 channels regulate cell volume via Ca 2+ -dependent mechanisms [79] and help maintain epithelial integrity and ductal function in response to osmotic challenge by high glucose. Inability to resolve osmotic changes has serious repercussions for the transport of Na + and the development of secondary hypertension associated with renal diseases, such as diabetic nephropathy. CX43 mediates GJIC between cells of the collecting duct, and high glucose (25 mmol/l) actually increases this expression and consequently improves cell-cell communication [80] . These data suggest a pivotal role for CX43-mediated gap junctions in the synchronisation of activity between cells of the cortical collecting duct in response to stimuli that mimic the osmotic and physical challenges associated with high glucose. To date, there is a wealth of information relating loss of gap junction expression and impaired cell communication to various secondary complications of diabetes in multiple tissue types [28] . In all instances, reduced connexin expression was shown to evoke pathophysiological changes through impaired GJIC, which ultimately facilitated loss of cell communication and impaired function. However, in the cortical collecting duct, it is interesting to speculate that glucose-evoked increases in connexin expression and enhanced cell communication may protect the duct from further glucose-induced damage, including alterations in re-absorptive capacity, associated with more established, progressive diabetic nephropathy.
The functional consequences of these data remain to be confirmed, and it should be noted that some cells change their connexin expression pattern in culture [81] . Investigators should bear this in mind when extrapolating in vitro cell work to the clinical scenario.
Conclusion
To help synchronise activity and coordinate function within different regions of the nephron, connexins mediate direct gap junction-associated cell-cell communication as well as local paracrine intercellular signalling from hemichannels. In diabetic nephropathy, these small proteins play a vital role in orchestrating an integrated functional response against osmotic, fibrotic and metabolic assault. This review outlines growing evidence that connexins offer a viable future therapeutic target for the control and treatment of a number of renal diseases, including diabetic nephropathy.
